Cited by 37Endometriosis Research and TreatmentOvarian function and disordersReproductive Biology and Fertility

Effect of GnRH agonist before IVF on outcomes in infertile endometriosis patients: a randomized controlled trial

Rodríguez-Tárrega, Elisabet, Monzo, Ana M., Quiroga, Ramiro, Polo-Sánchez, Patrocinio, Fernández-Colom, Pedro, Monterde-Estrada, Mercedes, Novella-Maestre, Edurne, Pellicer, Antonio·2020·Reproductive BioMedicine Online

Abstract

Research question Does 3-months of gonadotrophin releasing hormone agonist (GnRHa) treatment before IVF improve clinical pregnancy rate in infertile patients with endometriosis? Design Single-blind, placebo-controlled clinical trial of 200 infertile women with endometriosis assigned to use GnRHa (study group) or placebo (control group) for 3 months before IVF. Clinical, embryological outcomes and stimulation parameters were analysed. Clinical pregnancy rate was the primary endpoint. In a subgroup of 40 patients, follicular fluid levels of oestradiol, testosterone and androstendione were measured. Gene expression profile of CYP19A1 was analysed in cumulus and mural granulosa cells. Results Implantation or clinical pregnancy rate were not significantly different between the two groups. Clinical pregnancy rates were 25.3% and 33.7% in the study and control groups, respectively (P = 0.212). Cumulative live birth rate was not significantly different: 22.0% (95% CI 13.0 to 31.0) in the study group and 33.7% (95% CI 24.0 to 44.0) in the control group (P = 0.077). Ovarian stimulation was significantly longer and total dose of gonadotrophins significantly higher in the study group (both P < 0.001). Serum oestradiol levels on the day of HCG were significantly lower in the study group (P = 0.001). Cancellation rate was significantly higher in the study group (P = 0.042), whereas cleavage embryos were significantly more numerous in the control group (P = 0.023). No significant differences in the expression of CYP19A1 gene in mural or cumulus granulosa cells or steroid levels in follicular fluid between the two groups were observed, but testosterone was significantly lower in the study group (P < 0.001). Conclusion Three-months of GnRHa treatment before IVF does not improve clinical pregnancy rate in women with endometriosis.

Integrity signals

Registry

Crossref · 10.1016/j.rbmo.2020.06.020

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Following gonadotropin suppression prior to IVF, women with endometriosis showed reduced follicular testosterone relative to unaffected women.

    “Following a period of gonadotropin suppression prior to in vitro fertilization (IVF), women with endometriosis showed reduced follicular testosterone relative to unaffected women (Rodríguez‐Tárrega et al., 2020).”

    From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Rodríguez‐Tárrega et al., 2020

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rodríguez-Tárrega, E., Monzo, A. M., Quiroga, R., Polo-Sánchez, P., Fernández-Colom, P., Monterde-Estrada, M., Novella-Maestre, E., & Pellicer, A.
Affiliations
Hospital Universitari i Politècnic La Fe (ES)
Corresponding author
Rodríguez-Tárrega, Elisabet
Venue
Reproductive BioMedicine Online
Publisher
Elsevier BV
Published
2020-10
Volume
41
Issue
4
Pages
653-662
ISSN
1472-6483 (ISSN-L)
OpenAlex
W3039806799
Cited by
34
References
44
Citations by year
2026: 3 · 2025: 3 · 2024: 11 · 2023: 5 · 2022: 5 · 2021: 6
FWCI
3.53
Type
journal article
Language
en
Open access
closed
Locations
  • Reproductive BioMedicine Online (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ferring Pharmaceuticals
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
Keywords
GnRH agonist, endometriosis, in vitro fertilization, infertility, clinical pregnancy rate, ovulation induction, CYP19A1, aromatase gene expression, granulosa cells, cumulus cells, testosterone, estradiol, embryo cleavage, live birth rate
MeSH terms
Adult, Androstenedione, Aromatase, Endometriosis, Estradiol, Female, Fertilization in Vitro, Humans, Infertility, Female, Gonadotropin-Releasing Hormone, Luteolytic Agents, Pregnancy, Prospective Studies, Testosterone, Follicular Fluid, Single-Blind Method, Triptorelin Pamoate, Pregnancy Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review